Expanded Access [Ga-68] PSMA-11 PET Imaging
NCT04800068 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-01-21
Summary
In this expanded access IND study, Mayo Clinic in Rochester MN offers \[Ga-68\] PSMA-11 PET/CT or PET/MR imaging to patients who meet criteria.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
[Ga-68] PSMA-11 PET/CT
Imaging scan
- DIAGNOSTIC_TEST
-
[Ga-68] PSMA-11 PET/MR
Imaging scan
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer
NCT03689582 ·Status: TERMINATED ·Phase: PHASE2
-
Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT04348682 ·Status: APPROVED_FOR_MARKETING
-
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
NCT07209878 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
NCT05160597 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
NCT04179968 ·Status: COMPLETED ·Phase: PHASE2
-
68Ga-PSMA-11 PET in Patients With Prostate Cancer
NCT05197257 ·Status: COMPLETED ·Phase: PHASE3
-
Ga-68-PSMA-11 in High-risk Prostate Cancer
NCT03362359 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ga-68 MAA Distribution in PAE Patients
NCT04243824 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
NCT05415228 ·Status: NO_LONGER_AVAILABLE
-
68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer
NCT04483414 ·Status: WITHDRAWN ·Phase: PHASE2
-
Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard
NCT04159090 ·Status: UNKNOWN ·Phase: NA
-
68Ga-P3 PET/CT Imaging in Prostate
NCT05940259 ·Status: RECRUITING ·Phase: NA
-
Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CT
NCT04846894 ·Status: UNKNOWN ·Phase: NA
-
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
NCT03768349 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
68Ga-PSMA PET/CT Imaging in Assessment of Prostate Cancer
NCT05134064 ·Status: COMPLETED
-
Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions
NCT04867603 ·Status: COMPLETED
-
The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer
NCT04936334 ·Status: COMPLETED ·Phase: PHASE2
-
68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer
NCT04216134 ·Status: COMPLETED ·Phase: PHASE1
-
Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions
NCT03213951 ·Status: COMPLETED
-
68Ga-AAZTA-093 PET/CT: First-in-human Study
NCT06437496 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Ga-68-PSMA-11 in Men With Prostate Cancer
NCT05744115 ·Status: TERMINATED ·Phase: PHASE3
-
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer
NCT04484701 ·Status: ACTIVE_NOT_RECRUITING
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462508 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
NCT03187990 ·Status: COMPLETED ·Phase: NA
-
PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study
NCT04176497 ·Status: TERMINATED ·Phase: PHASE2